Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
PO Box
# 1365
Atlanta, GA 30322Phone+1 404-778-5526Fax+1 404-778-4655
Summary
- Dr. Andrew H. Miller is William P. Timmie Professor and Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia. He is an internationally recognized expert in interactions between the brain and immune system as they relate to depression. His work has demonstrated that during immune activation, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate, while altering neurocircuits relevant to motivation and reward as well as anxiety and alarm. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy (cytokine antagonist) for the treatment of depression. He has produced over 300 scholarly publications, won numerous research, teaching and mentoring awards including the Anna Monika Award for research in mood disorders. He is also an ISI highly cited researcher and is a Board-Certified Psychiatrist voted as a Top Doctor in Psychiatry.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Consultation-Liaison Psychiatry, 1985 - 1986
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1981 - 1984
- Medical College of Georgia at Augusta UniversityClass of 1981
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- GA State Medical License 1994 - 2025
- NY State Medical License 1982 - 1994
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
- Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment Start of enrollment: 2006 Oct 06
- A Study of Infliximab for Treatment Resistant Major Depression Start of enrollment: 2008 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.Andrew H Miller, Michael Berk, Gilles Bloch, Veronique Briquet-Laugier, Carinne Brouillon
Brain, Behavior, and Immunity. 2025-01-17 - DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism.Canhua Xiao, Gang Peng, Karen N Conneely, Hongyu Zhao, Jennifer C Felger
Molecular Psychiatry. 2025-01-01 - Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.Mandakh Bekhbat, Zhihao Li, Boadie W Dunlop, Michael T Treadway, Neeti D Mehta
Brain, Behavior, and Immunity. 2024-12-16
Journal Articles
- What Does Plasma CRP Tell Us About Peripheral and Central Inflammation in Depression?Andrew H Miller, Ebrahim Haroon, David R Goldsmith, Trusharth A Patel, Nature
Press Mentions
- Why Antidepressant Duloxetine Was RecalledOctober 28th, 2024
- Evidence Growing for Inflammation’s Role in Elevating Risk for Psychiatric IllnessAugust 26th, 2024
- Inflammation Linked to Weakened Reward Circuits in DepressionDecember 1st, 2015
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: